Pete Stavropoulos
Stock Analyst at Cantor Fitzgerald
(0)
# 3798
Out of 5,240 analysts
46
Total ratings
25.00%
Success rate
-0.95%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Voyager Therapeutics | Initiates Coverage On: Overweight | 6 | 5.23 | 9.56% | 1 | Jan 10, 2025 | |
Arcturus Therapeutic... | Reiterates: Overweight | n/a | n/a | n/a | 5 | Dec 16, 2024 | |
KalVista Pharma | Reiterates: Overweight | n/a | n/a | n/a | 1 | Dec 9, 2024 | |
Alector | Reiterates: Overweight | n/a | n/a | n/a | 5 | Nov 26, 2024 | |
Annexon | Reiterates: Overweight | n/a | n/a | n/a | 9 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 107 107 | 35.26 | 203.46% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | n/a | n/a | n/a | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | n/a | n/a | n/a | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 | 4.69 | 6.61% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 | 1.63 | 697.55% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 15 | n/a | n/a | 2 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 | 9.54 | -16.14% | 1 | Mar 20, 2023 |